News
-
-
-
COMMUNIQUÉ DE PRESSE
1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary
1933 Industries Inc. announces acquisition of membership interests in Alternative Medicine Association LC by its subsidiary, FN Pharmaceuticals, from Company's Executive VP. Purchase price of USD$50,000 to be paid through issuance of common shares -
COMMUNIQUÉ DE PRESSE
Anbio introduces cutting-edge “Point of Care” technology in Europe
Anbio Biotechnology expands into the EU market with the AF-100 C immunoassay analyzer, offering over 70 assays to enhance patient care. The cutting-edge analyzer revolutionizes point-of-care testing, delivering rapid and accurate results for healthcare providers -
COMMUNIQUÉ DE PRESSE
Passing of the baton at init SE’s Managing Board
Dr. Jürgen Greschner is passing on his position to Martin Timmann at init SE's Managing Board, with the transition set for 1st October 2024. Greschner's successor has a successful track record in revenue growth and international sales -
-
-
-
COMMUNIQUÉ DE PRESSE
Thailand’s National Anti-Corruption Commission issues guidelines to tackle corruption aiming to promote more foreign investors’ confidence
The National Anti-Corruption Commission (NACC) of Thailand issues guidelines to prevent corruption and boost foreign investors' confidence. Efforts to combat corruption highlighted -
